A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer
Molecular Carcinogenesis · 2026-08 · 65 (8) · 938-947
DOI: 10.1002/mc.70124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 15.05.2026. Verfasst von Xiaolu Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Lung Neoplasms, RNA, Transfer. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chongqing Natural Science Foundation, Chongqing Municipal Training Program of Innovation and Entrepreneurship for Undergraduates.
Abstract (Originalsprache)
As a promising candidate in liquid biopsy, tRNA‐derived small RNAs (tsRNAs) have been implicated as potential diagnostic biomarkers for cancer; however, the diagnostic potential of serum cell‐free tsRNAs in non‐small cell lung cancer (NSCLC) remains unexplored. This study aimed to develop a combinatorial model based on serum cell‐free tsRNA signatures and evaluated its diagnostic performance for NSCLC detection. Through systematic screening from the tsRFun database, we identified 32 NSCLC‐related differentially expressed tsRNAs, whose predicted target genes were significantly enriched in the MAPK pathway. Four MAPK pathway‐associated tsRNAs were selected for further validation due to their robust discriminatory power in distinguishing NSCLC patients from healthy control. Subsequent validation via quantitative RT‐PCR confirmed significantly elevated serum levels of tsRNA‐Thr‐5‐0039, tsRNA‐Thr‐5‐0044, and tsRNA‐Cys‐5‐0011 in NSCLC patients compared to healthy controls. The final combinatorial diagnostic model incorporating these three tsRNAs achieved an AUC of 0.83 (95% CI: 0.70–0.95), with 71.8% accuracy, 52.6% sensitivity, and 90.0% specificity. The three‐tsRNA model outperformed individual tsRNAs in diagnostic efficiency. In conclusion, these findings highlight the diagnostic potential of circulating tsRNA signatures as a minimally invasive liquid biopsy approach, offering new perspectives for early diagnosis of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical College, Chongqing Medical University, Chongqing, China.
- The Second Clinical College, Chongqing Medical University, Chongqing, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medicine, Chongqing Medical University, Chongqing, China.
- Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Ying Zhang
Förderung
- Chongqing Natural Science Foundation
- Chongqing Municipal Training Program of Innovation and Entrepreneurship for Undergraduates
Zitieren
APA
Hu, X., Yang, X., Jin, P., Tian, J., Tao, C., Tang, Y., & Zhang, Y. (2026). A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer. Molecular Carcinogenesis, 65(8), 938-947. https://doi.org/10.1002/mc.70124
Vancouver
Hu X, Yang X, Jin P, Tian J, Tao C, Tang Y, et al. A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer. Molecular Carcinogenesis. 2026;65(8):938-947. doi:10.1002/mc.70124
BibTeX
@article{Hu2026,
author = {Hu, Xiaolu and Yang, Xiaoyu and Jin, Peng and Tian, Jiaxin and Tao, Chuntao and Tang, Yishu and Zhang, Ying},
title = {A Combinatorial Model of Serum tsRNAs as a Diagnostic Biomarker for Non‐Small Cell Lung Cancer},
journal = {Molecular Carcinogenesis},
year = {2026},
volume = {65},
number = {8},
pages = {938--947},
doi = {10.1002/mc.70124}
}
EUVIMED